...
首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >ENHANCED BIOAVAILABILITY OF GLIMEPIRIDE THROUGH MICROEMULSION BASED TRANSDERMAL GELS
【24h】

ENHANCED BIOAVAILABILITY OF GLIMEPIRIDE THROUGH MICROEMULSION BASED TRANSDERMAL GELS

机译:通过微乳基皮肤凝胶增强格列吡肽的生物利用度

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The objective of the present research work was to conduct in vivo pharmacokinetic study of microemulsion based transdermal gel of glimepiride for evaluating the enhanced bioavailability. Saturation solubility studies of the drug were conducted in various solvents and oils. Labrafil M 1944 CS, Tween 80 and Transcutol P were used as oil phase, surfactant and cosurfactants respectively for the preparation of microemulsion based on the results from solubility studies. Surfactant to cosurfactant ratio was fixed as 1:2 in all the formulations. Microemulsion based gel was prepared using carbopol 934 as gelling agent and oil to smix ratio of 1:9. In vivo pharmacokinetic studies conducted in rabbits revealed that the bioavailability of microemulsion based gel was increased 5.4 times compared to oral suspension demonstrating avoidance of first pass metabolism and oral degradation. This indicates the effective management of plasma profile of glimepiride when it is administered as microemulsion based gel through transdermal route.
机译:本研究工作的目的是进行格列美脲微乳基透皮凝胶的体内药代动力学研究,以评估增强的生物利用度。在各种溶剂和油中进行了药物的饱和溶解度研究。根据溶解度研究的结果,分别将Labrafil M 1944 CS,Tween 80和Transcutol P用作油相,表面活性剂和助表面活性剂,以制备微乳液。在所有配方中,表面活性剂与辅助表面活性剂之比均固定为1:2。以carbopol 934为胶凝剂,油与s mix 的比例为1:9,制备了微乳液型凝胶。对兔子进行的体内药代动力学研究表明,与口服混悬液相比,基于微乳的凝胶的生物利用度提高了5.4倍,这表明可以避免首过代谢和口服降解。这表明当格列美脲以微乳为基础的凝胶通过透皮途径给药时,有效控制了格列美脲的血浆分布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号